| Epidemiology from Literature | | Cohort | Year | Country | Test | Subjects | Positive (%) | Bibliography | | 0 - No Criteria | 2014 | Croatia | IgE | 500 | 0.600 | 20140211, Mladineo I
| | 1.1 - Asymptomatic | 2014 | Spain | IgE | 50 | 4.000 | 20140625, Armentia A
| | 1.11 - Esophagitis, Diagnosed | 2014 | Spain | IgE | 67 | 10.400 | 20140625, Armentia A
| | 1.2.1 - Asthma, Diagnosed (Adults) | 2012 | Sweden | IgE | 96 | 0.000 | 20120528, Patelis A
| | 1.5 - Atopic Dermatitis, Diagnosed | 2013 | Germany | IgE | 140 | 0.000 | 20130111, Ott H
| | 1.5 - Atopic Dermatitis, Diagnosed | 2009 | Germany | IgE | 20 | 10.000 | 20091005, Ott H
| | 1.7 - Urticaria, Diagnosed | 2013 | Spain | IgE | 25 | 39.000 | 20131113, Daschner A
| | 1.9 - Pollen Allergy | 2014 | Spain | IgE | 50 | 6.000 | 20140625, Armentia A
| | 10.1 - Normal Control | 2012 | Belgium | IgE | 27 | 0.000 | 20110223, De Knop KJ
| | 10.1 - Normal Control | 2009 | Belgium | IgE | 26 | 3.850 | 20091121, Ebo DG
| | 3.1.4 - Source Sensitized (SPT, IgE) | 2012 | Spain | IgE | 10 | 100.000 | 20120327, Gamboa PM
| | 3.2.1 - Source Sensitized (IgE) | 2013 | Italy | IgE | 15 | 26.700 | 20130702, Caballero ML
| | 3.2.1 - Source Sensitized (IgE) | 2013 | Spain | IgE | 20 | 92.000 | 20131113, Daschner A
| | 3.2.1 - Source Sensitized (IgE) | 2013 | Spain | IgE | 17 | 52.900 | 20130702, Caballero ML
| | 3.2.1 - Source Sensitized (IgE) | 2008 | Spain | IgE | 84 | 66.660 | 20080711, Caballero ML
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2009 | Belgium | IgE | 22 | 0.000 | 20091121, Ebo DG
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2009 | Belgium | IgE | 20 | 0.000 | 20091121, Ebo DG
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Belgium | IgE | 37 | 0.000 | 20090826, Ebo DG
| | 5.2.4 - Source Exposed, Adults (Symptoms, IgE) | 2007 | Spain | IgE | 30 | 93.300 | 20070531, Rodriguez-Perez R
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2012 | Belgium | IgE | 99 | 4.040 | 20110223, De Knop KJ
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2013 | Italy | IgE | 42 | 66.700 | 20130702, Caballero ML
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2013 | Spain | IgE | 35 | 85.700 | 20130702, Caballero ML
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2012 | Spain | IgE | 25 | 100.000 | 20120327, Gamboa PM
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2008 | Spain | IgE | 53 | 86.800 | 20080413, Ibarrola I
| | 6.2 - General Population (Adults) | 2012 | Sweden | IgE | 371 | 0.000 | 20120528, Patelis A
| | 6.6 - Source Exposure | 2004 | Spain | IgE | 174 | 13.800 | 20040123, Toro C
| | 5.1.1 - Source Exposed (Symptoms) | 2002 | Spain | IgE (IB) | 49 | 85.700 | 2002, Caballero ML
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2000 | Spain | IgE (IB) | 20 | 85.000 | 2000, Moneo I
|
|
Loading...
Ani s 1
